The effect of finasteride for the treatment of melasma
Phase 3
- Conditions
- melasma.Chloasma
- Registration Number
- IRCT2016031627077N1
- Lead Sponsor
- Ahwaz Jondishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
inclusion criteria: patient with melasma and would like to participate in the study
exclusion criteria: pregnant and lactating women, patients treated with anti androgenic drugs, oral contraceptive use
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Melasma. Timepoint: Baseline, the end of the first month, the end of second month, the end of the third month. Method of measurement: By observing the amount of blur, uniformity and percentage of skin involvement in four areas of the forehead, right cheek, left cheek and chin.
- Secondary Outcome Measures
Name Time Method Satisfaction with treatment. Timepoint: end of treatment. Method of measurement: Interviews with patients.